CYCLOCYTIDINE, AN ANTITUMOR CYTIDINE ANALOG RESISTANT TO CYTIDINE DEAMINASEHOSHI A; KURETANI K.1979; GANN MONOGR. CANCER RES.; JPN; DA. 1979; NO 24; PP. 143-157; BIBL. 74 REF.Article

DIFFERENCES BETWEEN 5-FLUORO-2'-DEOXYURIDINE AND 5-FLUOROURIDINE IN THEIR CYTOTOXIC EFFECT ON GROWTH OF MURINE LYMPHOMA L5178Y CELLS IN IN VIVO AND IN VITRO SYSTEMSKANZAWA F; HOSHI A; KURETANI K et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 8; PP. 1087-1092; BIBL. 21 REF.Article

THE DIFFERENCE IN MECHANISM OF ACTION OF 5-FLUOROURACIL AND ITS NUCLEOSIDES IN L5178Y CELLSYOSHIDA M; HOSHI A; KURETANI K et al.1980; J. PHARMACOBIO-DYN.; ISSN 0386-846X; JPN; DA. 1980; VOL. 3; NO 8; PP. 374-379; BIBL. 10 REF.Article

PREVENTION OF ANTITUMOR EFFECT OF 5-FLUOROURACIL BY HYPOXANTHINEYOSHIDA M; HOSHI A; KURETANI K et al.1978; BIOCHEM. PHARMACOL.; GBR; DA. 1978; VOL. 27; NO 24; PP. 2979-2982; BIBL. 8 REF.Article

ANTITUMOR ACTIVITY OF HALOACETYLPHENOTHIAZINES AGAINST ASCITES SARCOMA-180 = ACTION ANTITUMORALE DES HALOACETYLPHENOTHIAZINES SUR LE SARCOME 180 A FORME ASCITIQUEKANZAWA F; HOSHI A; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 2; PP. 225-229; BIBL. 13 REF.Serial Issue

ANTITUMOR ACTIVITY OF CYCLOCYTIDINE IN A VARIETY OF TUMORS = ACTIVITE ANTITUMORALE DE LA CYCLOCYTIDINE DANS UNE VARIETE DE TUMEURSHOSHI A; KANZAWA F; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 3; PP. 353-360; BIBL. 12REF.Serial Issue

INFLUENCE OF DURATION OF EXPOSURE TO 5-FLUOROURACIL ON ANTIPROLIFERATING ACTIVITY AGAINST CULTURED MURINE LYMPHOMACELLSKANZAWA F; HOSHI A; KURETANI K et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 5; PP. 757-759; BIBL. 14 REF.Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL IN MICE BEARING ASCITES SARCOMA 180IIGO M; KURETANI K; HOSHI A et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 2; PP. 345-349; BIBL. 13 REF.Article

ISOLATION AND CHARACTERIZATION OF THE MURINE LYMPHOMA L5178Y CELL LINE HIGHLY RESISTANT TO 5-FLUOROURACILKANZAWA F; HOSHI A; KURETANI K et al.1980; J. PHARMACOBIO-DYN.; ISSN 0386-846X; JPN; DA. 1980; VOL. 3; NO 8; PP. 390-394; BIBL. 20 REF.Article

MODE OF ACTION OF 5-FLUOROURIDINE 5'-PHOSPHATE IN VIVO AND IN VITRO.YOSHIDA M; KURETANI K; HOSHI A et al.1978; CHEM. PHARM. BULL.; JAP.; DA. 1978; VOL. 26; NO 2; PP. 429-434; BIBL. 8 REF.Article

INFLUENCE OF ROUTE OF ADMINISTRATION OF ANTILEUKEMIC ACTIVITY OF CYCLOCYTIDINE = INFLUENCE DE LA VOIE D'ADMINISTRATION SUR L'ACTION ANTILEUCEMIQUE DE LA CYCLOCYTIDINEHOSHI A; KANZAWA F; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 2; PP. 279-280; BIBL. 3 REF.Serial Issue

MECHANISM OF CYTOTOXICITY OF 5-FLUOROURACIL: DISTINCTION BETWEEN THE IRREVERSIBLE CYTOTOXIC EFFECT OF 5-FLUOROURIDINE AND THE REVERSIBLE CYTOTOXIC EFFECT OF 5-FLUORO-2'-DEOXYURIDINE ON MURINE LYMPHOMA L5178Y CELLS IN CULTUREKANZAWA F; HOSHI A; KURETANI K et al.1980; Z. KREBSFORSCH. KLIN. ONKOL.; ISSN 0084-5353; DEU; DA. 1980; VOL. 98; NO 1; PP. 85-90; BIBL. 18 REF.Article

ANTITUMOR ACTIVITY OF ALKYLESTERS OF 1-BETA -D-RIBOFURANOSYL-5-FLUOROURACIL-5'-PHOSPHATE AGAINST MURINE LYMPHOMA L5178Y RESISTANT TO 1-BETA -D-RIBOFURANOSYL-5-FLUOROURACILKAZAWA F; HOSHI A; KURETANI K et al.1979; BULL. CANCER; FRA; DA. 1979; VOL. 66; NO 5; PP. 497-501; ABS. FRE; BIBL. 13 REF.Article

EFFECT OF CENTROPHENOXINE ON CYCLOPHOSPHAMIDE CONCENTRATION IN BLOOD.KANZAWA F; HOSHI A; KURETANI K et al.1976; GANN; JAP.; DA. 1976; VOL. 67; NO 4; PP. 595-599; BIBL. 9 REF.Article

EFFECT OF STRUCTURAL MODIFICATION ON ANTITUMOR ACTIVITY OF HALOACETYLPHENOTHIAZINES = EFFET DE MODIFICATION STRUCTURALE SUR L'ACTIVITE ANTITUMORALE DES HALOACETYLPHENOTHIAZINESKANZAWA F; HOSHI A; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 3; PP. 375-378; BIBL. 4REF.Serial Issue

EFFECT AND TOXICITY OF COMBINATION TREATMENT INCLUDING CYCLOCYTIDINE OR CYTOSINE ARABINOSIDE IN "L1210 AND SARCOMA-180 SYSTEMSHOSHI A; KANZAWA F; IIGO M et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 5; PP. 539-546; BIBL. 12 REF.Article

ANTITUMOR ACTIVITY OF PROTEIN MOIETY OF PSEUDOMONAS AERUGINOSA ENDOTOXIN = ACTION ANTITUMORALE DE LA FRACTION PROTEIQUE DE L'ENDOTOXINE DE P. A.HOSHI A; KANZAWA F; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 4; PP. 503-504; BIBL. 13 REF.Serial Issue

EXCRETION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN URINE OF MICEIIGO M; NAKAMURA A; KURETANI K et al.1981; J. PHARMACOBIO-DYN; ISSN 0386-846X; JPN; DA. 1981; VOL. 4; NO 7; PP. 490-496; BIBL. 8 REF.Article

ANTITUMOR ACTIVITY OF ALKYLDISULFIDE DERIVATIVES OF 6-MERCAPTOPURINES AGAINST L-1210 LEUKEMIAINOMATA M; FUKUOKA F; HOSHI A et al.1981; J. PHARMACOBIOL-DYN.; ISSN 0386-846X; JPN; DA. 1981; VOL. 4; NO 12; PP. 928-932; BIBL. 5 REF.Article

ANTITUMOR ACTIVITY OF 1,2-DIAMINOCYCLOHEXANE-PLATINUM COMPLEXES AGAINST SARCOMA-180 ASCITES FORMKIDANI Y; INAGAKI K; IIGO M et al.1978; J. MEDICIN. CHEM.; USA; DA. 1978; VOL. 21; NO 12; PP. 1315-1318; BIBL. 17 REF.Article

ANTITUMOR ACTIVITY OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN A VARIETY OF EXPERIMENTAL TUMORS.HOSHI A; IIGO M; NAKAMURA A et al.1976; GANN; JAP.; DA. 1976; VOL. 67; NO 5; PP. 725-731; BIBL. 15 REF.Article

ACTION OF 5-FLUOROCYCLOCYTIDINE ON CULTURED L-5178Y CELLSYOSHIDA M; HOSHI A; KURETANI K et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 5; PP. 561-564; BIBL. 12 REF.Article

PYRIMIDINE NUCLEOSIDES. V. SYNTHESES OF CARCINOSTATIC HALOGENO-CYCLONUCLEOSIDESKANAI T; ICHINO M; HOSHI A et al.1972; J. MEDICIN. CHEM.; U.S.A.; DA. 1972; VOL. 15; NO 12; PP. 1218-1221; BIBL. 16REF.Serial Issue

ANTITUMOR ACTIVITY OF 1-ALKYLCARBAMOYL DERIVATIVES OF 5-FLUOROURACIL AGAINST L1210 LEUKEMIA.HOSHI A; IIGO M; NAKAMURA A et al.1978; CHEM. PHARM. BULL.; JAP.; DA. 1978; VOL. 26; NO 1; PP. 161-165; BIBL. 16 REF.Article

INTERACTION OF ANTITUMOR AGENTS INCLUDING DOXORUBICIN OR DAUNORUBICIN IN SARCOMA-180 SYSTEM.IIGO M; KANZAWA F; NAKAMURA A et al.1977; GANN; JAP.; DA. 1977; VOL. 68; NO 4; PP. 459-464; BIBL. 15 REF.Article